Search Results - Daniel Molnar

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Cost-effectiveness analysis of respiratory syncytial virus vaccination with the adjuvanted prefusion F protein vaccine (RSVPreF3 OA) for adults ≥60 years old in Japan

    Cost-effectiveness analysis of respiratory syncytial virus vaccination with the adjuvanted prefusion F protein vaccine (RSVPreF3 OA) for adults ≥60 years old in Japan by Akiko Mizukami, Victor Preckler, Frederik Verelst, Taizo Matsuki, Yufan Ho, Daisuke Kurai, Daniel Molnar

    Published 2024-12-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis

    The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged ≥60 years in Japan: results of a Markov model analysis by Daisuke Kurai, Akiko Mizukami, Victor Preckler, Frederik Verelst, Daniel Molnar, Taizo Matsuki, Yufan Ho, Ataru Igarashi

    Published 2024-12-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: